| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion
|
Rahbar, Kambiz
|
|
2018
|
45 |
6 |
p. 1076-1077
|
artikel
|
| 2 |
A first-in-man PET study of [18F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5
|
Warnock, Geoffrey
|
|
2017
|
45 |
6 |
p. 1041-1051
|
artikel
|
| 3 |
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
|
Pascoal, Tharick A.
|
|
2018
|
45 |
6 |
p. 1021-1030
|
artikel
|
| 4 |
Antitumor effects of radionuclide treatment using α-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma model
|
Ohshima, Yasuhiro
|
|
2018
|
45 |
6 |
p. 999-1010
|
artikel
|
| 5 |
Assessment of alteration in liver 18F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score
|
Salomon, Thibault
|
|
2017
|
45 |
6 |
p. 941-950
|
artikel
|
| 6 |
11C–acetate PET/CT: a potential alternative of transcranial biopsy for grading cerebral gliomas
|
Hatazawa, Jun
|
|
2018
|
45 |
6 |
p. 1011
|
artikel
|
| 7 |
Cancer metastasizes to the bone marrow and not to the bone: time for a paradigm shift!
|
Høilund-Carlsen, Poul Flemming
|
|
2018
|
45 |
6 |
p. 893-897
|
artikel
|
| 8 |
Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent
|
Plyku, Donika
|
|
2018
|
45 |
6 |
p. 989-998
|
artikel
|
| 9 |
Correction to: Biological tumour volumes of gliomas in early and standard 20–40 min 18F-FET PET images differ according to IDH mutation status
|
Unterrainer, M.
|
|
2018
|
45 |
6 |
p. 1078
|
artikel
|
| 10 |
Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [123I]FP-CIT SPECT images
|
Oliveira, Francisco P. M.
|
|
2017
|
45 |
6 |
p. 1052-1062
|
artikel
|
| 11 |
FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance
|
Helsen, Nils
|
|
2018
|
45 |
6 |
p. 1063-1071
|
artikel
|
| 12 |
68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer
|
Sachpekidis, Christos
|
|
2018
|
45 |
6 |
p. 904-912
|
artikel
|
| 13 |
Hybrid MR-PET of brain tumours using amino acid PET and chemical exchange saturation transfer MRI
|
da Silva, N. A.
|
|
2018
|
45 |
6 |
p. 1031-1040
|
artikel
|
| 14 |
Imaging αvβ3 integrin expression in skeletal metastases with 99mTc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment
|
Cook, Gary J. R.
|
|
2018
|
45 |
6 |
p. 898-903
|
artikel
|
| 15 |
Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index
|
Nicolini, Silvia
|
|
2018
|
45 |
6 |
p. 923-930
|
artikel
|
| 16 |
Is it time to change our vision of tumor metabolism prior to immunotherapy?
|
Grizzi, Fabio
|
|
2018
|
45 |
6 |
p. 1072-1075
|
artikel
|
| 17 |
Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity
|
Garske-Román, Ulrike
|
|
2018
|
45 |
6 |
p. 970-988
|
artikel
|
| 18 |
PSA-stratified detection rates for [68Ga]THP-PSMA, a novel probe for rapid kit-based 68Ga-labeling and PET imaging, in patients with biochemical recurrence after primary therapy for prostate cancer
|
Derlin, Thorsten
|
|
2018
|
45 |
6 |
p. 913-922
|
artikel
|
| 19 |
Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis
|
Kramer, G. M.
|
|
2018
|
45 |
6 |
p. 951-961
|
artikel
|
| 20 |
The relationship between local recurrences and distant metastases in prostate cancer: can 11C-choline PET/CT contribute to understand the link?
|
Giovacchini, Giampiero
|
|
2018
|
45 |
6 |
p. 962-969
|
artikel
|
| 21 |
The roles of 11C-acetate PET/CT in predicting tumor differentiation and survival in patients with cerebral glioma
|
Kim, Soyoung
|
|
2018
|
45 |
6 |
p. 1012-1020
|
artikel
|
| 22 |
Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment
|
Mayerhoefer, Marius E.
|
|
2018
|
45 |
6 |
p. 931-940
|
artikel
|
Tijdschrift beschrijving